NCT06346743View on ClinicalTrials.gov

Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Neonatal Jaundice.

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2024

Conditions

Physiological Neonatal JaundicePhysiological Hyperbilirubinaemia

Interventions

DRUG

Fenofibrate

Single dose of Fenofibrate will be given at dose of 10mg/Kg along with phototherapy for 24 hours before next blood sampling

DEVICE

Phototherapy

only phototherapy will be given for 24 hours before next blood sampling

Trial Locations (1)

54000

Services Institute of Medical Sciences, Lahore

All Listed Sponsors

lead

Muhammad Zark

OTHER_GOV

NCT06346743 - Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Neonatal Jaundice. | Biotech Hunter | Biotech Hunter